关键信息
-
基因名
PLEKHB2
- 应用
-
别名
Evectin-2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96CS7
-
表达区间
1-222aa
-
分子量
40.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
PLEKHB2, a member of the Pleckstrin homology (PH) domain-containing protein family, has garnered attention in recent years due to its potential roles in cellular signaling and immune responses. This protein is primarily expressed in various hematopoietic cells and has been implicated in processes such as cell adhesion, migration, and survival, making it significant in both normal physiological functions and pathological conditions, including cancer and autoimmune diseases. Recent studies suggest that PLEKHB2 may modulate pathways related to cell proliferation and apoptosis, thereby influencing tumorigenesis and immune system regulation. Given its multifaceted roles, researchers are increasingly focusing on the production and characterization of recombinant PLEKHB2 proteins to elucidate the underlying mechanisms of its function. By generating these proteins in heterologous systems, scientists aim to investigate their structural properties, interaction with other biomolecules, and functional implications in cellular contexts. Understanding PLEKHB2's detailed characteristics could lead to novel therapeutic strategies targeting its pathways, with promising applications in cancer immunotherapy and treatment of immune-related disorders. The ongoing research into PLEKHB2 recombinant proteins is pivotal for advancing our knowledge of cellular dynamics and developing innovative approaches for disease management.
